Press Release | October 22, 2019 | Food & Farm Innovation, Sustainable Fuels, Bio-based Manufacturing, Bio Economy, Intellectual Property, Capital Formation, Human Health, Drug Development Process, Cost & Value of Biopharmaceuticals
“What has set the U.S. biotech sector apart has been thoughtful, bipartisan public policy approaches that create a favorable climate in which to undertake the lengthy and risky job of investing in and developing the next biotech breakthroughs.”